Medical Cannabis Services Australia

Medical Cannabis FAQ

We are happy to answer all the the questions you have regarding medical cannabis

Frequently Asked Questions

Medical Cannabis Services (MCS) was opened in 2017. The company originated in Canada as Medical Marijuana Services (MMS) in 2013 and has become one of the leading Canadian cannabis clinics. Over 10,000+ people processed and the highest customer service ratings in the industry. We expanded to Australia to help your citizens access cannabis at a compassionate price. We are the lowest priced clinic due to our experience and the use of telemedicine to save you time and allow you easy of use.

There is no specific list of what is covered and what is not covered. The condition must be shown to provide some benefit through evidence that it may be helpful in the treatment of that condition. There are many conditions that that information exists for and a partial list of them is as follows: Chronic pain, PTSD, Fibromyalgia, sleep disorders, epilepsy, MS, Insomnia, Migraine, IBS, Arthritis, Chemo-induced nausea, anxiety, and body spasms.

No, many forms of medical cannabis treatment involve the non psycho-active materials in the cannabis plant such as CBD. CBD only treatments are THC free and do not have the “high” that is associated with THC.

No, today’s cannabis treatments come in many forms such as oral spray, edible oils, gel caps with many more options coming on line all the time.

No, you must have a known medical condition that you have tried other forms of treatment for, before applying for medical cannabis. If you have a medical condition that you have suffered from and have had treated with no results or not the results you hoped for, then cannabis may be an option to try. It never hurts to ask, so contact MCS today.

Medical Cannabis Services estimate the current approval timeline to be approximately 3 days-1 week. Timelines vary by state and by the complexity of the condition being applied for. Every case is evaluated on a case by case basis and MCS offers no guarantee of approval.

The team at Medical Cannabis Services facilitates access for the patient to be evaluated by one of our doctors. The Medical Cannabis Services team then assist the doctor in completing the government application form for the Special Access Scheme B (SAS-B). The TGA requires information on the condition being treated, other medications that have been tested by the patient and names of your medical practitioners including the consulting specialists.

To begin, a patient must take our free screening consultation. This will see if you are able to register to see a doctor with MCS. Next, in order to be approved for medical cannabis to treat your condition you must go through the process of applying for the Special Access Scheme with the TGA. MCS facilitates the process for you and provides access to compassionate doctors by handling all the paperwork for your application. To start simply fill out the short request for a free screening. Please contact us via our registration form

Our Fee Schedule

Initial Screening FREE

$100 Initial consultation with doctor.

$100 Due immediately after initial consultation. Administration and processing fees and submission to TGA .

$95 Prior to 30 day follow-up consultation. (Mandatory)

$95  Prior to 60 day review. (Mandatory)

$95 2 Month follow-ups (Discretion of the Doctor)

Renewal $100

Missed appointments $80 without 48 hours notice. Sorry! It very rarely happens. Prices are subject to change without notice.

Bank Transfers

Medical Cannabis Services Pty. Ltd.



Telehealth saves time and money. Telemedicine is a expanding technology to connect doctors with patients over the internet using a secure online video platform. Your appointment is private and discreet and from the comfort of your own home or office. Estimated saving/year based on industry survey is 300/person.

No, not at this time. All medical practitioners are free to prescribe any product based on their determinations and freely choose your medical cannabis products.

Patients who’s conditions are not listed in the conditions the TGA (Therapeutic Goods Administration) accepts, are less likely to receive approval from the TGA (Therapeutic Goods Administration) for medicinal cannabis. However, if you would still like to discuss your case with our doctors, please Contact MCS. All cases are different and many factors can change this scenario.

It depends on what cannabis products you are prescribed and for what conditions. Things like the approval status of a drug determine what is and is not covered.

Contraindications for medicinal cannabis treatment Products containing THC are generally not appropriate for patients who:

  • Have a history of hypersensitivity to any cannabinoid or to smoke (if the cannabis is smoked)
  • Have severe cardio-pulmonary disease with occasional hypo-tension (low blood pressure), possible hypertension (high blood pressure), syncope (loss of consciousness) or tachycardia (rapid heart rate)
  • Suffer from respiratory diseases such as asthma or chronic obstructive pulmonary disease (COPD)
  • Patients with severe liver or renal disease, including chronic hepatitis C
  • Have a personal history of psychiatric disorders or a family history of schizophrenia
  • Have a history of substance abuse
  • severe liver or renal disease
  • Are women of childbearing age not on a reliable contraceptive, planning to become pregnancy, are pregnant, or are breastfeeding.

Quality and safety are the main reasons you should switch to a legal source of medical cannabis if you are a current user. Street cannabis can contain contaminants like pesticides and mold that are not safe to consume. Medical grade cannabis has been tested for purity and is contaminant free.

Yes, the patient will have to have a second consultation. How often you see the doctor varies by patient and condition but you are required to meet with them at least once in the first three months of your treatment so the initial process of using medical cannabis can be fully monitored and safety is insured.

The known side-effects from medicinal cannabis treatment (both CBD and THC) include fatigue and sedation, vertigo, nausea and vomiting, fever, decreased or increased appetite, dry mouth, and diarrhea. THC-containing compounds are also known to cause the psychotropic effects typically associated with cannabis such as feeling ‘high’.

Drug driving is a criminal offense. Care must be taken when consuming medical cannabis not to drive while under the influence of cannabis. Patients should consult with their doctor before driving or operating large machinery and equipment. Medical cannabis does not affect all patients the same way. Both CBD and THC can cause adverse reactions with other medications and currently these affects are not all known. THC takes many days to clear the system and can be found in urine for many days following use.  All states in Australia have Mobile Drug Testing and can show cannabis use up to 12 hours after use.

Patients should not drive or operate machinery while being treated with medicinal cannabis that contains THC. All states in Australia have Mobile Drug Testing. Currently all drivers that test positive will be charged.

Each producer sets their own pricing. Patients can expect to spend about $150-$250 per month.

Medicinal Cannabis comes in many forms today with none requiring the smoking of cannabis. Flowers can be vaporized or eaten for effect. Oils are the most common form of dosage.

Medicinal cannabis products can be purchased from any pharmacy legally with special access in place. After that, MCS works hard to find a close location that is easy to purchase from and assist in finding pricing and programs to help the patient incur these costs.

No. At the current time Medicinal Cannabis is not listed on the Pharmaceutical Benefits Scheme (PBS) and therefor not covered by the PBS. This will likely change in the next couple of years as more products are tested and verified for registration with the PBS.

If you have any questions, please ask. We are always here to help! Contact MCS here.